Is Fevertree Drinks Perfectly Positioned for Sustainable Success?

Photo of author
Written By Faith Boluwatife

Since January, Fevertree Drinks, a UK-based mixer drinks manufacturer and brand, has seen its stock price rise by over 13%. This increase is particularly intriguing given that both the company’s trading update released in late January and its full-year 2023 results released in March were not particularly encouraging.

Nonetheless, the stock price jumped 6.4% and 12.4% respectively on both occasions. Even after the most recent update, which reported positive sales momentum, the stock rose by 1.9%.

While this upward trend is notable, there are uncertainties about whether the price can continue to rise. There are both risks and supporting factors to consider for the company’s outlook in 2024. Here’s a detailed assessment of what might be next for Fevertree Drinks.

Outlook for 2024

Credits: DepositPhotos

The company’s outlook for 2024 is promising, with an 8% revenue growth forecast. The Fevertree brand itself is expected to grow even faster, by 10%. This distinction is important due to the acquisition of the German drinks distributor Global Drinks Partnership (GDP) in 2020, which includes other brands.

Despite this, the Fevertree brand remains dominant in the European market, contributing 26% of the overall revenue for 2023.

The profit outlook is even better. The gross margin is expected to improve by 6 percentage points to 38%, the highest in three years. Additionally, the adjusted EBITDA margin is projected to reach 15%, a significant improvement from the 8.4% seen in 2023.

Past Experience Encourages Caution

Despite the optimistic outlook, past performance suggests caution. The company missed its guidance last year, indicating that initial projections should be taken with a grain of salt. Initially, Fevertree Drinks projected a 15.5% revenue increase, but this was later revised to 11.8%. The actual growth came in much lower, at just 6%.

Similarly, the adjusted EBITDA guidance was missed. The initial expectation was a 1.8% year-on-year decline, but the actual decline was 23.2%. This underperformance was largely due to underwhelming demand conditions in the UK market and inflationary pressures.

These challenges were evident from the start of last year, suggesting that the company’s initial projections were overly optimistic.

Revenue Forecast is Achievable

Fevertree Drinks seems to have learned from last year’s experience. The revenue guidance for 2024 is more moderate, at 8%, which is lower than the compounded annual growth rate (CAGR) of approximately 9% over the past five years. This forecast appears achievable, especially given the improved demand conditions in the UK market.

The UK’s food and beverages service GDP, relevant for assessing the company’s market, has shown improvement recently. With a 2.4% growth in March 2024, this segment is now a key support for consumer-facing services GDP.

Adjusted EBITDA Outlook

The adjusted EBITDA margin projections for 2024 look ambitious at 15%, compared to 8.4% in 2023. This translates to an expected absolute adjusted EBITDA of GBP 59 million, a 94% increase from last year.

There is a basis for this optimism. In the second half of 2023, the company saw a near doubling of the adjusted EBITDA figure to GBP 20.3 million from the first half. The adjusted EBITDA margin also improved from 5.8% in H1 2023 to 10.8% in H2 2023.

Additionally, Fevertree Drinks expects cost inflation pressures to ease. Specifically, glass price inflation, which significantly impacted the gross margin in 2023, is expected to decrease as a new glass supplier has been contracted. This alone could bring the gross margin close to the projected 38%.

Operating expenses are projected to be 23% of revenues this year, which aligns with the 23.7% seen last year. This, combined with the gross profit projection, supports the adjusted EBITDA forecast.

The Market Multiples

Assuming the net profits to adjusted EBITDA ratio remains constant at 50%, the absolute profit figure would be GBP 29.8 million (USD 37.9 million). This results in a forward price-to-earnings (P/E) ratio of 42.3x, significantly lower than the 72.4x seen previously. The figure is also lower than the trailing twelve months (TTM) P/E of 81.5x.

However, it is not much lower than the five-year average forward P/E of 44.6x, indicating limited further upside. Nevertheless, dividends add to the returns on the stock, with a forward dividend yield of 1.87%.

Despite the high dividend payout ratio of 126.3% in 2023, it could improve to a more acceptable 66.5% if the company’s forecasts are accurate.

What’s Next?

Credits: DepositPhotos

There are likely gains to be made from Fevertree Drinks’ stock, driven by price upside and dividends. The stock could also benefit from an improvement in the UK economy and lower expected inflation. The company’s moderate revenue forecast for this year is more likely to be met or even upgraded, in contrast to last year’s disappointments.

Furthermore, Fevertree Drinks’ strong position as a mixer drinks provider suggests long-term growth potential. It might be a good time to start accumulating the stock, especially during price dips.

Overall, Fevertree Drinks appears to be a promising investment, with a positive outlook for both the near and long term.

 

DISCLAIMER

You should read and understand this disclaimer in its entirety before joining or viewing the website or email/blog list of SmallCapStocks.com (the “Publisher”). The information (collectively the “Advertisement”) disseminated by email, text or other method by the Publisher including this publication is a paid commercial advertisement and should not be relied upon for making an investment decision or any other purpose. The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation. The track record, gains, upside, and/or losses mentioned in the Advertisement, if any, should not be considered as true or accurate or be the basis for an investment. The Publisher does not verify the accuracy or completeness of any information included in the Advertisement. While the Publisher does not charge for the SMS service, standard carrier message and data rates may apply. To unsubscribe from receiving promotional text messages to your phone sent via an autodialer, using your phone reply to the sender’s phone number with the word STOP or HELP for help.

The Advertisement is not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. The Advertisement is not a disclosure document. The Advertisement is only a favorable snapshot of unverified information about the advertised company. An investor considering purchasing the securities, should always do so only with the assistance of his legal, tax and investment advisors. Investors should review with his or her investment advisor, tax advisor or attorney, if and to the extent available, any information concerning a potential investment at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at www.sec.gov; the Financial Industry Regulatory Authority (the "FINRA") at www.FINRA.org, and relevant State Securities Administrator website and the OTC Markets website at www.otcmarkets.com. The Publisher cautions investors to read the SEC advisory to investors concerning Internet Stock Fraud at www.sec.gov/consumer/cyberfr.htm, as well as related information published by the FINRA on how to invest carefully. Investors are responsible for verifying all information in the Advertisement. As an advertiser, we do not verify any information we publish. The Advertisement should not be considered true or complete.

The Publisher does not offer investment advice or analysis, and the Publisher further urges you to consult your own independent tax, business, financial and investment advisors concerning any investment you make in securities particularly those quoted on the OTC Markets. Investing in securities is highly speculative and carries an extremely high degree of risk. You could lose your entire investment if you invest in any company mentioned in the Advertisement. You acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser and we are not qualified to act as such. You acknowledge that you will consult with your own independent, tax, financial and/or legal advisers regarding any decisions as to any company mentioned here. We have not determined if the Advertisement is accurate, correct or truthful. The Advertisement is compiled from publicly available information, which include, but are not limited to, no cost online research, magazines, newspapers, reports filed with the SEC or information furnished by way of press releases. Because all information relied upon by us in preparing an advertisement about an issuer comes from a public source, it is not reliable, and you should not assume it is accurate or complete.

By your subscription to our profiles, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer and privacy policy which can be viewed at the following link: www.SmallCapStocks.com/Disclaimer and www.SmallCapStocks.com/Privacy-Policy

By accepting the Advertisement, you agree and acknowledge that any hyperlinks to the website of (1) a client company, (2) the party issuing or preparing the information for the company, or (3) other information contained in the Advertisement is provided only for your reference and convenience. The advertiser is not responsible for the accuracy or reliability of these external sites, nor is it responsible for the content, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on the Publisher, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink.